Quarterly report [Sections 13 or 15(d)]

SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES (Details)

v3.25.1
SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
License and other revenues
Research and development costs    
Non-cash stock-based compensation 2,701 1,546
Total research and development costs 9,941 7,207
General and administrative costs    
Total general and administrative costs 9,786 7,123
Other segment items [1] (7,698) 17,248
Net loss (12,029) (31,578)
Research and Development Expense [Member]    
Research and development costs    
Salaries & related costs 4,681 3,555
Non-cash stock-based compensation 670 346
Other general and administrative costs [2] 4,590 3,306
General and Administrative Expense [Member]    
Research and development costs    
Salaries & related costs 3,653 2,262
Non-cash stock-based compensation 2,031 1,200
Other general and administrative costs [3] 2,895 2,310
General and administrative costs    
Pre-commercial preparation costs $ 1,207 $ 1,351
[1] Other segment items includes royalties, interest income, interest expense, change in fair value of warrant and derivative liabilities and other income.
[2] Other research and development expenses include, but are not limited to lab supplies, preclinical and development costs, clinical trial costs, preclinical manufacturing and manufacturing facility costs, costs associated with regulatory approvals, depreciation on lab supplies and manufacturing facilities, and consultant-related expenses.
[3] Other general and administrative expenses primarily consist of office facility costs, public reporting company related costs, professional fees (e.g., legal expenses) and other general operating expenses not otherwise included in research and development expenses.